|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400088359 |
|
最近更新日期: Date of Last Refreshed on: |
2024-08-16 09:32:26 |
|
注册时间: Date of Registration: |
2024-08-16 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
高级外科专科护士主导的多学科预康复管理模式在胃肠肿瘤手术患者中的应用研究 |
|
Public title: |
Research on the application of multidisciplinary pre-rehabilitation management model led by senior surgical nurses in patients undergoing gastrointestinal tumor surgery |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
高级外科专科护士主导的多学科预康复管理模式在胃肠肿瘤手术患者中的应用研究 |
|
Scientific title: |
Research on the application of multidisciplinary pre-rehabilitation management model led by senior surgical nurses in patients undergoing gastrointestinal tumor surgery |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
刘曼丽 |
研究负责人: |
刘曼丽 |
|
Applicant: |
Manli Liu |
Study leader: |
Manli Liu |
|
申请注册联系人电话: Applicant telephone: |
+86 135 6030 8216 |
研究负责人电话:
Study leader's |
+86 135 6030 8216 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
liumanli201004@163.com |
研究负责人电子邮件: Study leader's E-mail: |
liumanli201004@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广东省广州市天河区黄埔大道西601号 |
研究负责人通讯地址: |
广东省广州市天河区黄埔大道西601号 |
|
Applicant address: |
No. 601, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province |
Study leader's address: |
No. 601, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
暨南大学附属第一医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Jinan University |
||
|
研究负责人所在单位: |
暨南大学附属第一医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Jinan University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY-2023-365 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
暨南大学附属第一医院涉人的科学研究伦理审查委员会 |
||
|
Name of the ethic committee: |
The Ethics Review Committee of the First Affiliated Hospital of Jinan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-28 00:00:00 | ||
|
伦理委员会联系人: |
黄瑶 |
||
|
Contact Name of the ethic committee: |
Yao Huang |
||
|
伦理委员会联系地址: |
广东省广州市天河区黄埔大道西601号 |
||
|
Contact Address of the ethic committee: |
No. 601, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 302 0868 8217 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
liumanli201004@163.com |
|
研究实施负责(组长)单位: |
暨南大学附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of Jinan University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省广州市天河区黄埔大道西601号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 601, Huangpu Avenue West, Tianhe District, Guangzhou City, Guangdong Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
暨南大学护理学院 |
||||||||||||||||||||||
|
Source(s) of funding: |
School of Nursing, Jinan University |
||||||||||||||||||||||
|
研究疾病: |
胃肠肿瘤 |
||||||||||||||||||||||
|
Target disease: |
Gastrointestinal tumors |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究拟探索以高级外科专科护士为主导、多学科协作的预康复管理模式,通过组建多学科预康复管理小组,综合考虑患者病情制定出科学、规范、个性化预康复策略,并将该策略用于胃肠肿瘤围手术期患者,以增强术前机体储备,减少术后并发症发生率,加快术后康复,改善临床结局,以期建立一套符合胃肠肿瘤患者预康复需求的标准化流程,也为临床医护人员探索一种新模式提供借鉴。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study intends to explore a pre-rehabilitation management model led by senior surgical nurses and multidisciplinary collaboration. In order to enhance the preoperative body reserve, reduce the incidence of postoperative complications, accelerate postoperative rehabilitation, and improve clinical outcomes, the strategy should be used to enhance the preoperative body reserve, reduce the incidence of postoperative complications, accelerate postoperative rehabilitation, and improve clinical outcomes, in order to establish a standardized process that meets the pre-rehabilitation needs of patients with gastrointestinal tumors, and also provide reference for clinical medical staff to explore a new model. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①符合胃肠肿瘤诊断标准,且经病理检查确诊; ②年龄18~75岁,性别不限; ③拟在我院行择期胃肠肿瘤切除手术治疗,手术日与住院日间隔>5天; ④首次治疗,术前未接受过放疗、化疗等抗肿瘤治疗; ⑤知晓且愿意参加本研究者。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Meet the diagnostic criteria for gastrointestinal tumors and be diagnosed by pathological examination; (2) Age 18~75 years old, gender is not limited; (3) Elective gastrointestinal tumor resection surgery is planned to be performed in our hospital, and the interval between the operation day and the hospitalization day is > 5 days; (4) For the first treatment, no anti-tumor therapy such as radiotherapy and chemotherapy has been received before surgery; (5) Those who know and are willing to participate in this study. |
||||||||||||||||||||||
|
排除标准: |
①美国医师协会麻醉分级(American Society of Anesthesiologists , ASA)≥3级[66]; ②有不能耐受预康复训练的合并症; ③存在肢体障碍等无法行运动锻炼; ④合并严重的肝肾功能不全、痛风或不能耐受乳清蛋白粉; ⑤有认知障碍等无法合作者者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) American Society of Anesthesiologists (ASA) classification ≥ 3 [66]; (2) Comorbidities that cannot tolerate pre-rehabilitation training; (3) Unable to exercise due to physical impairment; (4) Combined with severe liver and kidney insufficiency, gout or intolerance of whey protein powder; (5) Those who are unable to cooperate with those who have cognitive impairment or are unable to cooperate. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-08-30 00:00:00至 To 2024-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-08-30 00:00:00 至 To 2024-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用随机数字表法抽取80个数字,编号1~80,按入院顺序对应入号,根据随机数奇偶进行分组,奇数组为干预组,偶数组为对照组,随机将样本分为各40例。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
80 numbers were selected by random number table method, numbered 1~80, corresponding to the admission number according to the admission order, and grouped according to the random odd and even, the odd number group was the intervention group, and the even number group was the control group, and the samples were randomly divided into 40 cases each. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
NA |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Dot shared |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
A standard data collection and management system include a CRF and an electronic data capture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |